ThermoLife International LLC v. Neogenis Labs Incorporated

District Court, D. Arizona·Decided July 1, 2021·No. 2:18-cv-02980·Unknown

Opinion

WO

ThermoLife International LLC, No. CV-18-02980-PHX-DWL

Plaintiff, ORDER

v.

Neogenis Labs Incorporated,

Defendant. NeoGenis Labs Incorporated,

Counter-Claimant,

v.

ThermoLife International LLC and Ronald L. Kramer, Counter-Defendants.

Pending before the Court is ThermoLife’s renewed motion to voluntarily dismiss the Second Amended Complaint (“SAC”) without prejudice. (Doc. 202.) For the following reasons, the motion is granted. As discussed in earlier orders (Doc. 201), this action has been pending for almost three years. The Court and the parties have plodded through (1) two motions to dismiss ThermoLife’s complaint (Docs. 40, 63 [orders resolving motions]), resulting in the operative SAC; (2) two motions to dismiss HumanN’s counterclaims (Docs. 113, 176 [orders resolving motions]); (3) several requests to stay the case pending settlement discussions (Docs. 76, 78, 80, 82); (4) several requests to extend case deadlines (Docs. 116, 124, 184); and (5) various discovery disputes (Docs. 128, 130, 139, 142, 147, 175, 177). Fact discovery is set to close on July 23, 2021. (Doc. 208.) Even more discovery disputes have popped up in the last few days. (Docs. 219, 222.) Meanwhile, on February 11, 2021, ThermoLife filed separate lawsuit against HumanN in the Western District of Texas (the “Texas Litigation”), alleging that three of HumanN’s products—SuperBeets, BeetElite, and Neo40—infringe three of its patents: Patent Nos. 9,180,140 (the “’140 Patent”), 8,455,531 (the “’531 Patent”), and 10,555,968 (the “’968 Patent”). (Doc. 174-1.) On April 7, 2021, HumanN filed an answer and asserted counterclaims against ThermoLife in the Texas Litigation. (Doc. 174-2.) HumanN’s three products, and ThermoLife’s past assertions of infringement related to the ’140 and ’531 Patents, are also at issue in this lawsuit. Recently, ThermoLife requested a stay of HumanN’s counterclaims in this action, arguing (among other things) that the Texas Litigation would “resolve legal disputes between the parties that [would] be dispositive to likely all of HumanN’s counterclaims.” (Doc. 189 at 4, 6-8.) HumanN disagreed, arguing that it would be prejudiced by a stay and questioning whether the issues in the Texas Litigation would be dispositive of the issues in this action. (Doc. 199.) In this briefing, the parties also disputed whether, assuming a stay was granted, voluntary dismissal of ThermoLife’s claims would be proper. (Doc. 189 at 8-10; Doc. 199 at 13-17; Doc. 200 at 9-11.) The Court denied ThermoLife’s stay request, explaining (among other things) that “even if a ruling in the Texas Litigation might simplify the issues in this case, ThermoLife [had] not shown that such potential for simplification would justify an indefinite stay of this action, which has been pending for almost three years and is on the cusp of the close of discovery, when the alternative is forcing this Court to await a ruling in a suit filed only a few months ago on issues it is fully capable of resolving itself in due course.” (Doc. 201 at 7.) And “because ThermoLife conditioned the voluntary dismissal of its claims on the granting of a stay, the dismissal request [was] denied as moot.” (Id. at 8.) Soon afterward, ThermoLife filed the pending motion. (Doc. 202.) ThermoLife seeks to dismiss its claims without prejudice under Rule 41(a), with two conditions: “(1) that ThermoLife not refile the claims set forth in the Second Amended Complaint unless and until the Texas Patent Litigation finally resolves, including all appeals; and (2) if ThermoLife refiles the claims set forth in the Second Amended Complaint, it must refile them in this jurisdiction (absent an agreement by HumanN otherwise).” (Id. at 1.) On June 11, 2021, HumanN filed a response. (Doc. 209.) On June 23, 2021, ThermoLife filed a reply. (Doc. 218.)1 Neither side requested oral argument. I. Legal Standard Rule 41(a)(2) of the Federal Rules of Civil Procedure provides: Except as provided in Rule 41(a)(1), an action may be dismissed at the plaintiff’s request only by court order, on terms that the court considers proper. If a defendant has pleaded a counterclaim before being served with the plaintiff’s motion to dismiss, the action may be dismissed over the defendant’s objection only if the counterclaim can remain pending for independent adjudication. Unless the order states otherwise, a dismissal under [Rule 41(a)(2)] is without prejudice. Whether to grant a motion for voluntary dismissal under Rule 41(a)(2) is a matter of “the district court’s sound discretion.” Stevedoring Servs. of Am. v. Armilla Int’l B.V., 889 F.2d 919, 921 (9th Cir. 1989). “In exercising its discretion, the Court must make three separate determinations: (1) whether to allow the dismissal at all; (2) whether the dismissal should be with or without prejudice; and (3) what terms and conditions, if any, should be imposed.” Burnette v. Godshall, 828 F. Supp. 1439, 1443 (N.D. Cal. 1993). …

Free access — add to your briefcase to read the full text and ask questions with AI

ThermoLife International LLC v. Neogenis Labs Incorporated, (D. Ariz. 2021).

ThermoLife International LLC v. Neogenis Labs Incorporated (ThermoLife International LLC v. Neogenis Labs Incorporated) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related